Emphysema
A progressive lung disease marked by enlarged alveoli and reduced gas exchange.
Emphysema is a lower respiratory tract disease characterized by the permanent enlargement of air spaces (alveoli) in the lungs due to the breakdown of alveolar walls, reducing the surface area available for gas exchange. It is a major subtype of chronic obstructive pulmonary disease (COPD) when associated with significant airflow limitation, and it primarily affects middle-aged or older populations, often due to tobacco smoking or genetic factors such as alpha-1 antitrypsin deficiency.
- type
- Disease
- affected_system
- Lower respiratory tract
- primary_cause
- Tobacco smoking (most common); alpha-1 antitrypsin deficiency (genetic)
- subtypes
- Centrilobular, panlobular, paraseptal, paracicatricial
- global_mortality
- 3% of all deaths
- associated_conditions
- COPD, lung cancer, osteoporosis, pneumothorax
Lore & Background
Emphysema involves the breakdown of alveolar walls, leading to enlarged air spaces that replace spongy lung tissue. This reduces the total alveolar surface for gas exchange, lowering oxygen supply to the blood. The condition usually develops over time, with tobacco smoking as the primary risk factor; alpha-1 antitrypsin deficiency is a genetic risk factor that can cause earlier onset.
Reader's Guide
Emphysema is a significant lower respiratory tract disease and a major subtype of chronic obstructive pulmonary disease (COPD). Its hallmark is the permanent enlargement of alveoli due to the destruction of alveolar walls, which impairs gas exchange and leads to shortness of breath. The condition is most commonly caused by tobacco smoking, but genetic factors like alpha-1 antitrypsin deficiency can also cause it, often presenting earlier. There are four anatomical types: centrilobular (most common, associated with smoking), panlobular (linked to alpha-1 antitrypsin deficiency), paraseptal, and paracicatricial (associated with fibrosis). Only centrilobular and panlobular types cause significant airflow obstruction. Emphysema is a clear risk factor for lung cancer, and its presence in smokers confers higher mortality even without COPD. Osteoporosis is a common comorbidity, exacerbated by systemic corticosteroid use. Diagnosis often relies on imaging, but the condition is frequently underdiagnosed due to overlapping symptoms with other lung diseases.
Did You Know?
- Centrilobular emphysema is about 20 times more common than panlobular emphysema.
- Alpha-1 antitrypsin deficiency is a genetic risk factor that can lead to emphysema presenting earlier than typical smoking-related cases.
- Emphysema is a clear risk factor for lung cancer, with the risk strengthened in those who smoke.
- The intravenous use of methylphenidate (Ritalin) can lead to emphysematous changes known as Ritalin lung.
Frequently Asked Questions
Who is Emphysema?
Emphysema is a progressive condition of the lower respiratory tract in which the walls between tiny air sacs (alveoli) break down, permanently enlarging the spaces and shrinking the surface area available for oxygen and carbon dioxide to swap. It is classified as a major subtype of chronic obstructive pulmonary disease (COPD) whenever it produces measurable airflow limitation.
What are Emphysema's powers/role?
Its signature ability is the irreversible destruction of alveolar walls, which collapses the lung's gas-exchange surface and leaves patients increasingly breathless with even minimal exertion. Tobacco smoking is its most common trigger, though a genetic shortfall in alpha-1 antitrypsin can also set it off.
How does Emphysema's story end?
There is no cure; the damage to alveolar tissue is permanent, so the condition only progresses and worsens over time. Management centers on slowing decline through smoking cessation, inhaled bronchodilators, pulmonary rehabilitation, and, in the most severe cases, lung transplantation.
What are Emphysema's known variants?
Four recognized subtypes exist—centrilobular, panlobular, paraseptal, and paracicatricial—differing in exactly which regions of the acinus are destroyed. Centrilobular is the most frequently seen and is most tightly linked to long-term smoking, while panlobular is the variant most associated with alpha-1 antitrypsin deficiency.
More in Common Diseases & Disorders 1-24
Elsewhere in the Common Diseases & Disorders universe
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record